시장보고서 | 연간정보서비스 | 맞춤형시장조사 | 메일링 | 비교리스트
세계의 세포 용해 및 파괴 시장 보고서(2025년)
Cell Lysis And Disruption Global Market Report 2025
상품코드 : 1764278
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 175 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ￦ 6,222,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,490 ￦ 8,993,000
PDF (Site License) help
PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 8,490 ￦ 11,765,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

세포 용해 및 파괴 시장 규모는 향후 몇 년 동안 강력한 성장세를 보일 것으로 예상되며, 2029년까지 8.5%의 연평균 성장률로 74억 달러에 달할 것으로 예상됩니다. 예측 기간의 성장은 유전체학, 전사체학, 단백질체학, 단일세포 분석의 발전, 단일세포 분석의 응용 확대, 학술 연구 기관에 대한 자금 지원 확대, 전 세계 감염률 증가, 암 및 기타 만성질환의 발병률 증가에 기인합니다. 이 기간 동안 예상되는 주요 동향으로는 첨단 세포 용해 기술 개발, 샘플 조제 워크플로우 자동화, 랩온칩 시스템에 용해 기술 통합, 고성능 세포 용해 플랫폼의 등장, 선택적 용해를 위해 설계된 완충액 배합의 개선 등이 있습니다.

맞춤형 의료에 대한 관심이 높아지면서 향후 몇 년간 세포 용해 및 파괴 시장 확대의 원동력이 될 것으로 예상됩니다. 개인맞춤의료는 유전적 체질, 라이프스타일 등 개인별 특성에 따라 치료와 케어를 맞춤화하는 헬스케어 접근법을 말합니다. 개인맞춤의료에 대한 수요는 유전체기술의 발전으로 인해 증가하고 있습니다. 유전체 기술은 질병을 유발하는 유전적 변이를 정확하게 파악할 수 있도록 도와주며, 이를 통해 보다 타겟팅된 효과적인 치료를 가능하게 합니다. 맞춤형 의료에 대한 요구가 증가하면서 세포 용해 및 파괴의 사용이 증가하고 있습니다. 이러한 기술은 환자 샘플에서 데옥시리보핵산(DNA), 리보핵산(RNA), 단백질을 분리하는 데 필수적이며, 맞춤 치료 개발에 필요한 분자 분석을 가능하게 하기 때문입니다. 예를 들어, 2024년 2월 미국의 비영리단체인 개인맞춤의료연합(Personalized Medicine Coalition)은 미국 식품의약국(USFDA)이 2023년 희귀질환 환자를 위한 16개의 새로운 맞춤형 치료제를 승인했다고 보고했습니다. 이처럼 맞춤형 의료에 대한 관심이 높아짐에 따라 세포 용해 및 파괴 시장의 성장이 촉진될 것으로 예상됩니다.

세포 용해 및 파괴 시장의 주요 기업들은 미생물 유전체학에서 단일세포 분석의 효율성과 능력을 향상시키기 위해 단일 세포 미세유체 플랫폼과 같은 첨단 기술 개발을 우선시하고 있습니다. 단일 세포 마이크로유체 플랫폼은 마이크로 채널 내의 미세한 액체를 조작하여 개별 세포를 정확하게 분리, 취급, 분석할 수 있는 소형 장치입니다. 이 기술은 고성능의 자동화된 단일 세포 연구를 지원합니다. 예를 들어, 2024년 1월 리투아니아에 본사를 둔 생명공학 기업 Atrandi Biosciences Inc.는 Flux 플랫폼과 Single-Microbe DNA Barcoding Kit를 발표했습니다. 이 혁신은 반투과성 캡슐(SPC) 기술을 통합하여 다운스트림 반응의 무결성을 유지하면서 개별 미생물 세포의 효율적인 분리 및 용해를 용이하게 합니다. 이 플랫폼은 고성능 성능을 제공하도록 설계되어 정확한 미생물 유전체 정량화 및 DNA 시퀀싱을 가능하게 합니다. 이러한 발전은 워크플로우를 간소화하고 과학 분야 전반에 걸쳐 고해상도 분석을 보다 친숙하고 효과적으로 만들어 미생물 유전체학 및 단일 세포 연구를 발전시키는 데 필수적입니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장 : 금리, 인플레이션, 지정학, 무역 전쟁과 관세, 코로나와 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

제6장 시장 세분화

제7장 지역별·국가별 분석

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 개요

제31장 기타 주요 기업과 혁신적 기업

제32장 세계의 시장 경쟁 벤치마킹과 대시보드

제33장 주요 인수합병

제34장 최근의 시장 동향

제35장 시장 잠재력이 높은 국가, 전략

제36장 부록

ksm
영문 목차

영문목차

Cell lysis and disruption are processes that compromise or break the integrity of a cell's membrane, leading to the release of its internal contents. Cell lysis specifically involves breaking the cell membrane or wall through chemical, enzymatic, or biological methods. On the other hand, cell disruption encompasses a broader range of techniques, including mechanical methods such as sonication, bead milling, or homogenization, as well as non-mechanical strategies, which are particularly useful for more resilient cells like bacteria or yeast. Although cell lysis falls under the umbrella of cell disruption, both processes are aimed at accessing intracellular materials for use in research or biotechnology.

The primary products in cell lysis and disruption include reagents and consumables, as well as instruments. Reagents and consumables consist of chemical agents and single-use items-such as buffers, enzymes, detergents, tubes, and pipette tips-used to break open cells and extract their contents for downstream analysis. These processes are applied to a variety of cell types, including bacterial cells, mammalian cells, plant cells, and yeast, fungi, or algae. Applications include cell organelle isolation, protein extraction, downstream processing, and nucleic acid isolation. The end users span pharmaceutical and biotechnology companies, academic and research institutions, and others.

The cell lysis and disruption market research report is one of a series of new reports from The Business Research Company that provides cell lysis and disruption market statistics, including cell lysis and disruption industry global market size, regional shares, competitors with a cell lysis and disruption market share, detailed cell lysis and disruption market segments, market trends and opportunities, and any further data you may need to thrive in the cell lysis and disruption industry. This cell lysis and disruption market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The cell lysis and disruption market size has grown strongly in recent years. It will grow from $4.91 billion in 2024 to $5.34 billion in 2025 at a compound annual growth rate (CAGR) of 8.8%. Growth during the historic period can be attributed to the expansion of biopharmaceutical research and development efforts, the growing trend of outsourcing bioprocessing to contract development and manufacturing organizations (CDMOs), the demand for efficient upstream processing in biomanufacturing, increased investments in gene therapy research, and a rise in clinical trials utilizing viral vectors.

The cell lysis and disruption market size is expected to see strong growth in the next few years. It will grow to $7.40 billion in 2029 at a compound annual growth rate (CAGR) of 8.5%. Growth in the forecast period can be attributed to the advancement of genomics, transcriptomics, and proteomics, the increasing applications of single-cell analysis, expanded funding for academic and research institutions, the global rise in infectious disease prevalence, and the growing incidence of cancer and other chronic illnesses. Key trends anticipated during this period include the development of advanced cell lysis techniques, automation in sample preparation workflows, integration of lysis technologies into lab-on-chip systems, the emergence of high-throughput cell lysis platforms, and improved buffer formulations designed for selective lysis.

The growing emphasis on personalized medicine is expected to drive the expansion of the cell lysis and disruption market in the coming years. Personalized medicine refers to a healthcare approach that customizes treatment and care based on an individual's unique characteristics, such as genetic makeup and lifestyle. The demand for personalized medicine is increasing due to advancements in genomic technologies, which facilitate the precise identification of disease-causing genetic variations, thereby enabling more targeted and effective therapies. The rising need for personalized medicine supports the use of cell lysis and disruption, as these techniques are crucial for isolating Deoxyribonucleic Acid (DNA), Ribonucleic Acid (RNA), and proteins from patient samples, allowing for the molecular analysis necessary to develop customized treatments. For example, in February 2024, the Personalized Medicine Coalition, a US-based nonprofit organization, reported that the U.S. Food and Drug Administration (USFDA) approved 16 new personalized therapies for rare disease patients in 2023, a notable increase from 6 approvals in 2022. Thus, the growing focus on personalized medicine is expected to fuel the growth of the cell lysis and disruption market.

Leading companies in the cell lysis and disruption market are prioritizing the development of advanced technologies, such as single-cell microfluidic platforms, to improve the efficiency and capabilities of single-cell analysis in microbial genomics. Single-cell microfluidic platforms are compact devices that enable the precise isolation, handling, and analysis of individual cells by manipulating minute fluid volumes within microchannels. This technology supports high-throughput and automated single-cell research. For example, in January 2024, Atrandi Biosciences Inc., a biotechnology company based in Lithuania, introduced the Flux platform along with the Single-Microbe DNA Barcoding Kit. These innovations incorporate semi-permeable capsule (SPC) technology, which facilitates the efficient isolation and lysis of individual microbial cells while preserving the integrity of downstream reactions. The platform is designed to deliver high-throughput performance, enabling accurate microbial genome quantification and DNA sequencing. Such advancements are vital for progressing microbial genomics and single-cell research by streamlining workflows and making high-resolution analysis more accessible and effective across scientific disciplines.

In July 2023, QIAGEN N.V., a Netherlands-based company specializing in reagents and kits for cell lysis, entered into a partnership with Niba Labs to improve the precision, efficiency, and standardization of molecular diagnostics and drug development processes. This collaboration aims to leverage their combined expertise in digital polymerase chain reaction (PCR) assay development and sample testing to deliver customized solutions for biopharmaceutical companies. These solutions are designed to enhance nucleic acid quantification, increase the accuracy and reproducibility of viral vector titration, and address the growing demand for high-sensitivity analysis in cell and gene therapy. Niba Labs is a Slovenia-based biotechnology firm focused on analytics for cell and gene therapy applications.

Major players in the cell lysis and disruption market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Danaher Corporation, Merck KGaA, Becton Dickinson and Company (BD), Agilent Technologies Inc., IDEX Corporation, Bio-Rad Laboratories Inc., Qiagen N.V., Eppendorf AG, Miltenyi Biotec GmbH, Takara Bio Inc., Promega Corporation, New England Biolabs Inc., Cell Signaling Technology Inc., Covaris LLC, Microfluidics International Corp., Parr Instrument Company, Pion Inc., Analytik Ltd., Claremont BioSolutions LLC, Qsonica LLC.

North America was the largest region in the cell lysis and disruption market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in cell lysis and disruption report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the cell lysis and disruption market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The cell lysis and disruption market consists of revenues earned by entities by providing services such as contract cell lysis services, customized sample preparation services, cell disruption protocol development, analytical testing and validation services related to lysates. The market value includes the value of related goods sold by the service provider or included within the service offering. The cell lysis and disruption market also includes sales of bead-based lysis systems, microfluidizer-based cell disruption systems, and pressure-based cell disruptors. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Cell Lysis And Disruption Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on cell lysis and disruption market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for cell lysis and disruption ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The cell lysis and disruption market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Scope

Table of Contents

1. Executive Summary

2. Cell Lysis And Disruption Market Characteristics

3. Cell Lysis And Disruption Market Trends And Strategies

4. Cell Lysis And Disruption Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Cell Lysis And Disruption Growth Analysis And Strategic Analysis Framework

6. Cell Lysis And Disruption Market Segmentation

7. Cell Lysis And Disruption Market Regional And Country Analysis

8. Asia-Pacific Cell Lysis And Disruption Market

9. China Cell Lysis And Disruption Market

10. India Cell Lysis And Disruption Market

11. Japan Cell Lysis And Disruption Market

12. Australia Cell Lysis And Disruption Market

13. Indonesia Cell Lysis And Disruption Market

14. South Korea Cell Lysis And Disruption Market

15. Western Europe Cell Lysis And Disruption Market

16. UK Cell Lysis And Disruption Market

17. Germany Cell Lysis And Disruption Market

18. France Cell Lysis And Disruption Market

19. Italy Cell Lysis And Disruption Market

20. Spain Cell Lysis And Disruption Market

21. Eastern Europe Cell Lysis And Disruption Market

22. Russia Cell Lysis And Disruption Market

23. North America Cell Lysis And Disruption Market

24. USA Cell Lysis And Disruption Market

25. Canada Cell Lysis And Disruption Market

26. South America Cell Lysis And Disruption Market

27. Brazil Cell Lysis And Disruption Market

28. Middle East Cell Lysis And Disruption Market

29. Africa Cell Lysis And Disruption Market

30. Cell Lysis And Disruption Market Competitive Landscape And Company Profiles

31. Cell Lysis And Disruption Market Other Major And Innovative Companies

32. Global Cell Lysis And Disruption Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Cell Lysis And Disruption Market

34. Recent Developments In The Cell Lysis And Disruption Market

35. Cell Lysis And Disruption Market High Potential Countries, Segments and Strategies

36. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기